China Rolls Out Its First Four-Valent Covid Vaccine as Infections Spike

What’s new: Beijing and several other Chinese cities have started offering residents China’s first Covid-19 vaccine against four variants of the virus, as the country speeds up its vaccination drive to tackle a growing wave of infections.

The four-valent Covid vaccine, SCTV01E, is a recombinant protein vaccine developed by Beijing-based drugmaker Sinocelltech Group Ltd. It offers “better broad-spectrum protection” against the main variants identified by the World Health Organization — alpha, beta, delta and omicron, a researcher at the company said in a Beijing Daily report.